Wave Life Sciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $274.9M
Liabilities Breakdown FY2023
Total Liabilities: $227.4M
Asset Breakdown
Total Assets: $274.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $200.4M | 72.9% |
| Accounts Receivable | $21.1M | 7.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.1M | 4.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $40.4M | 14.7% |
Liabilities Breakdown
Total Liabilities: $227.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.8M | 5.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $214.6M | 94.4% |